COVID-19: CSIR institute to conduct clinical trials of antiviral drug Umifenovir

The drug has a good safety profile and acts by preventing entry of viruses into human cells and also by priming the immune system, according to a statement.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/37MbX4P
via IFTTT